Nayak Ramesh C, Sen Prosenjit, Ghosh Samit, Gopalakrishnan Ramakrishnan, Esmon Charles T, Pendurthi Usha R, Rao L Vijaya Mohan
Center for Biomedical Research, University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Blood. 2009 Aug 27;114(9):1974-86. doi: 10.1182/blood-2009-03-208900. Epub 2009 Jul 8.
Although the binding of endothelial cell protein C receptor (EPCR) to its ligands is well characterized at the biochemical level, it remains unclear how EPCR interaction with its ligands at the cell surface impacts its cellular trafficking. We characterized the cellular localization and trafficking of EPCR in endothelial cells and a heterologous expression system. Immunofluorescence confocal microscopy studies revealed that a majority of EPCR is localized on the cell surface in membrane microdomains that are positive for caveolin-1. A small fraction of EPCR is also localized intracellularly in the recycling compartment. Factor VIIa (FVIIa) or activated protein C binding to EPCR promoted the internalization of EPCR. EPCR and EPCR-bound ligands were endocytosed rapidly via a dynamin- and caveolar-dependent pathway. The endocytosed receptor-ligand complexes were accumulated in a recycling compartment before being targeted back to the cell surface. EPCR-mediated FVIIa endocytosis/recycling also resulted in transport of FVIIa from the apical to the basal side. In vivo studies in mice showed that blockade of EPCR with EPCR-blocking antibodies impaired the early phase of FVIIa clearance. Overall, our results show that FVIIa or activated protein C binding to EPCR promotes EPCR endocytosis, and EPCR-mediated endocytosis may facilitate the transcytosis of FVIIa and its clearance from the circulation.
尽管内皮细胞蛋白C受体(EPCR)与其配体的结合在生化水平上已得到充分表征,但EPCR在细胞表面与其配体的相互作用如何影响其细胞转运仍不清楚。我们对EPCR在内皮细胞和异源表达系统中的细胞定位和转运进行了表征。免疫荧光共聚焦显微镜研究表明,大多数EPCR定位于细胞表面富含小窝蛋白-1的膜微区。一小部分EPCR也定位于细胞内的再循环区室。凝血因子VIIa(FVIIa)或活化蛋白C与EPCR的结合促进了EPCR的内化。EPCR及其结合的配体通过一种依赖发动蛋白和小窝的途径迅速被内吞。内吞的受体-配体复合物在被靶向回到细胞表面之前,先在再循环区室中积累。EPCR介导的FVIIa内吞/再循环还导致FVIIa从顶端向基底侧转运。在小鼠体内的研究表明,用EPCR阻断抗体阻断EPCR会损害FVIIa清除的早期阶段。总体而言,我们的结果表明,FVIIa或活化蛋白C与EPCR的结合促进了EPCR的内吞作用,并且EPCR介导的内吞作用可能促进FVIIa的转胞吞作用及其从循环中的清除。